Preliminary Clinical Data From Ongoing Phase 2 Study With Enhancer of Zeste Homolog 2 (EZH2) Inhibitor CPI-0209 in Patients With Advanced Solid Tumors or Hematologic Malignancies

Kindler, H. ; Harvey, R.D. ; Duska, L.R. ; Gandhi, L. ; Sullivan, R.J. ; Gastinne, T. ; Kwiatek, M. ; García-Sancho, A.M. ; Hadar, N. ; Kann, L. ; Faulhaber, N. ; Drescher, C.

European journal of cancer (1990), 2022-10, Vol.174, p.S31-S32 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível